Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.894 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8938 |
High Similarity |
NPD3818 |
Discontinued |
0.8917 |
High Similarity |
NPD5494 |
Approved |
0.8718 |
High Similarity |
NPD2801 |
Approved |
0.8544 |
High Similarity |
NPD3817 |
Phase 2 |
0.8509 |
High Similarity |
NPD1247 |
Approved |
0.8491 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8443 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8418 |
Intermediate Similarity |
NPD1934 |
Approved |
0.84 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8373 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8373 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8323 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD919 |
Approved |
0.825 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8212 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8166 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8141 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8121 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8025 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8024 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD920 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7963 |
Intermediate Similarity |
NPD37 |
Approved |
0.7953 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7895 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD1607 |
Approved |
0.784 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7818 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7818 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD943 |
Approved |
0.7683 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7667 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5242 |
Approved |
0.764 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD2533 |
Approved |
0.764 |
Intermediate Similarity |
NPD2532 |
Approved |
0.764 |
Intermediate Similarity |
NPD2534 |
Approved |
0.764 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7595 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7531 |
Intermediate Similarity |
NPD5401 |
Approved |
0.75 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7473 |
Intermediate Similarity |
NPD5005 |
Approved |
0.747 |
Intermediate Similarity |
NPD6386 |
Approved |
0.747 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7456 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.744 |
Intermediate Similarity |
NPD5353 |
Approved |
0.744 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7436 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7436 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7414 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7384 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6777 |
Approved |
0.725 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD2344 |
Approved |
0.72 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7158 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7158 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6190 |
Approved |
0.712 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7072 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7062 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7049 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7035 |
Intermediate Similarity |
NPD5977 |
Approved |
0.703 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7005 |
Intermediate Similarity |
NPD6534 |
Approved |
0.6994 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6968 |
Remote Similarity |
NPD1876 |
Approved |
0.6959 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD7584 |
Approved |
0.6946 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6943 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD7874 |
Approved |
0.6939 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3266 |
Approved |
0.6923 |
Remote Similarity |
NPD3267 |
Approved |
0.6919 |
Remote Similarity |
NPD6279 |
Approved |
0.6919 |
Remote Similarity |
NPD6280 |
Approved |
0.6908 |
Remote Similarity |
NPD9268 |
Approved |
0.6904 |
Remote Similarity |
NPD7801 |
Approved |
0.6895 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6895 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.689 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6879 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6864 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD17 |
Approved |
0.6839 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6831 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6829 |
Remote Similarity |
NPD6100 |
Approved |
0.6829 |
Remote Similarity |
NPD6099 |
Approved |
0.6826 |
Remote Similarity |
NPD3887 |
Approved |
0.6818 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6815
|
Remote Similarity |
NPD1203 |
Approved |